Literature DB >> 15042580

Prostaglandin E(2) and 6-keto-prostaglandin F(1alpha) production is elevated following traumatic injury to sciatic nerve.

Naser Muja1, George H DeVries.   

Abstract

Sciatic nerve explants cultured either alone or in the presence of peritoneal macrophages were used to study prostaglandin E(2) (PGE(2)) and 6-keto-PGF(1alpha) production following traumatic peripheral nerve injury. Although barely detectable at early time points (1-3 h in vitro), the production of PGE(2) and 6-keto-PGF(1alpha) by sciatic nerve explants increased significantly after 18 h and remained elevated for up to 96 h. The cyclooxygenase-2 (COX-2) selective inhibitor, NS-398, inhibited PGE(2) and 6-keto-PGF(1alpha) production by injured sciatic nerve in a dose-dependent manner. Consistent with the observed effect of NS-398, peripheral nerve explants, as well as Schwann cells and perineural fibroblasts cultured from neonatal sciatic nerve, each contained COX-2 immunoreactivity after 24 h in vitro. Both Schwann cells and perineural fibroblasts produced significant amounts of PGE(2) and 6-keto-PGF(1alpha); but only in the presence of arachidonic acid. As observed for injured sciatic nerve, the production of PGE(2) and 6-keto-PGF(1alpha) by primary Schwann cells and perineural fibroblasts was completely inhibited by NS-398. Compared to macrophages cultured alone, macrophages cultured in the presence of sciatic nerve explants produced large amounts of PGE(2), whereas the level of 6-keto-PGF(1alpha) was unchanged. In contrast, macrophages treated with adult sciatic nerve homogenate did not produce significant amounts of either PGE(2) or 6-keto-PGF(1alpha) during the entire course of treatment. We conclude that injured sciatic nerves produce PGE(2) and 6-keto-PGF(1alpha) by a mechanism involving COX-2 activity and that macrophages produce large amounts of PGE(2) in response to soluble factors produced by injured nerve but not during the phagocytosis of peripheral nerve debris.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042580     DOI: 10.1002/glia.10349

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  12 in total

1.  Schwann cell-derived factors modulate synaptic activities at developing neuromuscular synapses.

Authors:  Guan Cao; Chien-Ping Ko
Journal:  J Neurosci       Date:  2007-06-20       Impact factor: 6.167

2.  Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats.

Authors:  Backil Sung; Shuxing Wang; Bei Zhou; Grewo Lim; Liling Yang; Qing Zeng; Jeong-Ae Lim; Jing Dong Wang; Jing X Kang; Jianren Mao
Journal:  Pain       Date:  2007-01-30       Impact factor: 6.961

3.  LXR agonist modifies neuronal lipid homeostasis and decreases PGD2 in the dorsal root ganglia in western diet-fed mice.

Authors:  Nadia Elshareif; Chaitanya K Gavini; Virginie Mansuy-Aubert
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

4.  The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage.

Authors:  Elsa-Marie Treutlein; Katharina Kern; Andreas Weigert; Neda Tarighi; Claus-Dieter Schuh; Rolf M Nüsing; Yannick Schreiber; Nerea Ferreirós; Bernhard Brüne; Gerd Geisslinger; Sandra Pierre; Klaus Scholich
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

5.  Antihyperalgesic and anti-inflammatory effects of atorvastatin in chronic constriction injury-induced neuropathic pain in rats.

Authors:  Nitya N Pathak; Venkanna Balaganur; Madhu C Lingaraju; Amar S More; Vinay Kant; Dhirendra Kumar; Dinesh Kumar; Surendra Kumar Tandan
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 6.  Arachidonic acid derivatives and their role in peripheral nerve degeneration and regeneration.

Authors:  Carlos Rodrigo Camara-Lemarroy; Emmanuel Irineo Gonzalez-Moreno; Francisco Javier Guzman-de la Garza; Nancy Esthela Fernandez-Garza
Journal:  ScientificWorldJournal       Date:  2012-09-10

7.  WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.

Authors:  Jie Wen; Melissa Jones; Mikiei Tanaka; Prabhuanand Selvaraj; Aviva J Symes; Brian Cox; Yumin Zhang
Journal:  J Neuroinflammation       Date:  2018-01-08       Impact factor: 8.322

8.  Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat.

Authors:  Alessio Filippo Peritore; Rosalba Siracusa; Roberta Fusco; Enrico Gugliandolo; Ramona D'Amico; Marika Cordaro; Rosalia Crupi; Tiziana Genovese; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

9.  Celecoxib accelerates functional recovery after sciatic nerve crush in the rat.

Authors:  Carlos R Cámara-Lemarroy; Francisco J Guzmán-de la Garza; Ernesto A Barrera-Oranday; Andrés J Cabello-García; Armando García-Tamez; Nancy E Fernández-Garza
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2008-11-26

Review 10.  Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: etiological contribution to complex regional pain syndromes (Part I).

Authors:  Fuzhou Wang; George B Stefano; Richard M Kream
Journal:  Med Sci Monit       Date:  2014-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.